Search

Author/Creator Padron, Eric

52. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide. (20th April 2016)

Authors:
Rollison, Dana E.; Shain, Kenneth H.; Lee, Ji‐Hyun; Hampras, Shalaka S.; Fulp, William; Fisher, Kate; Al Ali, Najla H.; Padron, Eric; Lancet, Jeffrey; Xu, Qiang; Olesnyckyj, Martha; Kenvin, Laurie; Knight, Robert; Dalton, William; List, Alan; Komrokji, Rami S.
Journal:
Cancer medicine
Issue:
Volume 5:Number 7(2016:Jul.)
Page Start:
1694
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

55. Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis. Issue 1 (2nd January 2022)

Authors:
Komrokji, Rami; Melody, Megan; al Ali, Najla; Chan, Onyee; Klimek, Virginia; Ball, Brian J.; Sekeres, Mikkael A.; Lucas, George; Maciejewski, Jaroslaw P.; Sallman, David A.; Padron, Eric; Kuykendall, Andrew; Lasho, Terra; Al-Kali, Aref; Naqvi, Kiran; Steensma, David P.; Garcia-Manero, Guillermo; ...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 1(2022)
Page Start:
199
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

56. Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium. (22nd December 2020)

Authors:
Komrokji, Rami S.; Al Ali, Najla H; Sallman, David; Padron, Eric; DeZern, Amy E.; Barnard, John; Roboz, Gail J.; Garcia‐Manero, Guillermo; List, Alan; Steensma, David P.; Sekeres, Mikkael A.
Journal:
Cancer medicine
Issue:
Volume 10:Number 2(2021)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

57. Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes. Issue 7 (30th May 2013)

Authors:
Mishra, Asmita; Corrales‐Yepez, Maria; Ali, Najla Al; Kharfan‐Dabaja, Mohamed; Padron, Eric; Zhang, Ling; Epling‐Burnette, Pearlie K.; Pinilla‐Ibarz, Javier; Lancet, Jeffrey E.; List, Alan F.; Komrokji, Rami S.
Journal:
American journal of hematology
Issue:
Volume 88:Issue 7(2013:Jul.)
Page Start:
566
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

58. What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?. Issue 11 (19th September 2021)

Authors:
Komrokji, Rami; Al Ali, Najla; Padron, Eric; Lancet, Jeffrey; Nazha, Aziz; Steensma, David; DeZern, Amy; Roboz, Gail; Garcia-Manero, Guillermo; Sekeres, Mikkael A.; Sallman, David
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 11(2021)
Page Start:
2762
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗